Clinical Trials Browser

Has results × Neoplasms × Dacarbazine × Clear all

NCT01227889 2017-10-04

A Study Comparing GSK2118436 to Dacarbazine (DTIC) in Previously Untreated Subjects With BRAF Mutation Positive Advanced (Stage III) or Metastatic (Stage IV) Melanoma

Phase 3 Completed

251 enrolled 21 charts

Melanoma, Neoplasms

NCT00110994 2015-06-08

Treatment for Subjects With Unresectable Stage III or Stage IV Melanoma

Phase 2 Completed

101 enrolled 21 charts

Melanoma, Neoplasms

NCT00246012 2013-08-19

A Safety and Efficacy Study of Intetumumab, Alone and in Combination With Dacarbazine, in Participants With Stage 4 Melanoma

Phase 1/2 Completed

144 enrolled 34 charts

Melanoma, Neoplasms